Elite in Cholangiocarcinoma (Bile Duct Cancer)
Check Dr. Mitesh J. Borad's experience treating your condition:
About Dr. Mitesh J. Borad

Mitesh Borad is a Hematologist and an Oncologist in Phoenix, Arizona. Borad has been practicing medicine for over 23 years and is rated as an Elite expert by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 20 other conditions, according to our data. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, Pancreatic Cancer, and Liver Cancer. He is licensed to treat patients in Louisiana, California, and Arizona. Borad is currently accepting new patients.

His clinical research consists of co-authoring 176 peer reviewed articles and participating in 26 clinical trials in the past 15 years. In particular, he has co-authored 58 articles and participated in 11 clinical trials in the study of Cholangiocarcinoma (Bile Duct Cancer).


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Mitesh J. Borad it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
5777 E Mayo Blvd, Phoenix, AZ 85054
Background & Education
Graduate Institution
Rowan University School Of Osteopathic Medicine, 2000
Hematology Oncology
Internal Medicine in CA
Hospital Affiliations
Mayo Clinic Hospital - Arizona
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

23 Clinical Trials

A Phase I, Multi-Center, Open Label, Dose De-Escalation and Expansion Study of Gemcitabine and Cisplatin With AG120 or Pemigatinib for Advanced Cholangiocarcinoma
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Patients With Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Melanoma or Endometrial Carcinoma
Pilot Study of Ponatinib in Biliary Cancer Patients With FGFR2 Fusions
A Pilot Study of a Rapid Access Platform for Investigational Drugs (RAPID) in Advanced Cancers
Phase I Trial of Intratumoral Injection of Vesicular Stomatitis Virus Expressing Human Interferon Beta in Patients With Sorafenib Refractory/Intolerant Hepatocellular Carcinoma, Advanced Solid Tumors With Liver Predominant Locally Advanced/Metastatic Disease or Subcutaneous/Cutaneous Lesions
A Single-Arm Feasibility Study of Gemcitabine, Cisplatin, and Nab-Paclitaxel as Neoadjuvant Therapy for Resectable Oncologically High-Risk Intrahepatic Cholangiocarcinoma
Phase II Trial of Trifluridine/Tipiracil in Combination With Irinotecan in Biliary Tract Cancers
A Phase I Study of the Safety and Tolerability of VLX600, an Iron Chelator, in Patients With Refractory Advanced Solid Tumors
A Phase IIa, Multicenter, Open-label Study to Assess the Safety and Efficacy of the Combination of BL-8040 and Pembrolizumab in Patients With Metastatic Pancreatic Cancer, the COMBAT Study
A Phase I/II Study of CX-4945 in Combination With Gemcitabine and Cisplatin in the Frontline Treatment of Patients With Cholangiocarcinoma
A Phase II/III, Multicenter, Randomized, Placebo-controlled Study of Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) as First-line Treatment of Biliary Tract Cancer
A Phase I/IIA Study of ABC294640 Alone and in Combination With Hydroxychloroquine Sulfate in the Treatment of Patients With Advanced, Unresectable Intra-hepatic, Perihilar and Extra-Hepatic Cholangiocarcinoma
View 20 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors